Jump to ContentJump to Main Navigation
Show Summary Details

European Journal of Nanomedicine

Editor-in-Chief: Hunziker, Patrick / Mollenhauer, Jan

Managing Editor: Löffler, Beat / Salieb-Beugelaar, Georgette

Editorial Board Member: Alexiou, Christoph / Balogh, Lajos / Barenholz, Yechezkel / Dawson, Kenneth / Fadeel, Bengt / Husseini, Ghaleb / Krol, Silke / Lee, Dong Soo / Lehr, Claus-Michael / Mangge, Harald / Müller, Bert / Peer, Dan / Scoles, Giacinto / Serruys, Patrick / Schwartz, Simo / Szebeni, Janos

4 Issues per year

CiteScore 2016: 1.06

SCImago Journal Rank (SJR) 2016: 0.411
Source Normalized Impact per Paper (SNIP) 2016: 0.360

    99,00 € / $149.00 / £75.00*

    See all formats and pricing
    More options …


    Your Benefits

    • Multidisciplinary approach to human diseases with nanoscience
    • Special attention to niches in the subject matter of EJNM
    • Wide audience – academic and beyond
    • Online publication ahead of print

    Aims and Scope

    The European Journal of Nanomedicine (EJNM) is a peer-reviewed quarterly journal dedicated to basic and clinical research in Nanomedicine. Its focus lies on the clinical application of nanoscience tools, methods and materials and on the exploration of the implications of Nanomedicine. EJNM covers topics from nano(bio)technological engineering and characterization to clinically translatable innovative prevention, diagnostics, and therapies of major as well as neglected human diseases. It addresses a multidisciplinary readership and provides a comprehensive outlook on the application of nanosciences for the benefit of patients.

    • Experimental, Analytical, (Pre-)Clinical, Preventive and Therapeutic Nanomedicine
    • Medical Nanomaterials
    • Nanobiotechnology
    • Nanodiagnostics
    • Nanotoxicity
    • Nano-Imaging Technologies
    • Vanguard Nano-Technologies
    • Implementation and Implications of Nanomedicine
    • Personalized Nanomedicine

    Article formats
    • Original Articles
    • Reviews
    • Short Communications
    • Opinion Papers
    • Letters to the Editor

    Please find all information on the submission process in our Instructions for authors.


    Type of Publication:

    scientists in chemistry, physics, engineering, pharmacology, molecular biology, biomedicine, and clinicians, addressing recipients in academic, industrial, and regulatory environments, the informed public and policymakers

    Submission of Manuscripts

    Instructions for Authors

    You can easily submit your manuscript online. You will be guided through the whole peer-reviewing and publishing process.

    Your benefits of publishing with us
    • Rapid publication times
    • No submission fee
    • Free color illustrations
    • High quality independent peer-review
    • Every article easily discoverable because of SEO and comprehensive abstracting and indexing services
    • Convenient citation tracking via e-mail alert
    • Secure archiving by De Gruyter and the independent archiving service Portico
    Submission process
    • Submission of your paper via our submission management tool
    • Single-blind peer review process
    • First decision aspired within 4 weeks
    • Ahead of print publication approx. 4 weeks after acceptance
    • Optional Open Access publication

    Please note
    • Manuscripts must be written in clear and concise English.
    • Where applicable, all authors must confirm in writing that they have complied with the World Medical Association Declaration of Helsinki regarding ethical conduct of research involving human subjects and/or animals. In the Materials and Methods Section, or in a separate section, the manuscript should contain a statement that the study has been approved by the Ethical Committee of the institution where the study was performed, and that the study subjects, or their legal guardians, gave informed consent for participation in the study. Before submitting your article please have a look at our Publication Ethics and Malpractice Statement and our copyright agreement
    • The ethics statements for the European Journal of Nanomedicine are based on the Committee on Publication Ethics (COPE) Best Practice Guidelines for Journal Editors and the “Uniform Requirements for Manuscripts (URM) Submitted to Biomedical Journals” of the International Committee of Medical Journal Editors
    • Our repository policy allows you to distribute 30 PDF copies of your published article to colleagues (the PDF has to include the information that it is an author's copy). Please also feel free to distribute the link to the online abstract
    • If you have any general questions please visit our FAQ page for authors or contact us at: editorial.nanomedicine@degruyter.com

    We look forward to receiving your manuscript!

    Hybrid Open Access

    For complete details on hybrid open access publishing at De Gruyter please see: https://www.degruyter.com/page/560

    Effective 1st January 2016, authors from an institution affiliated with either the Association of Dutch Universities (VSNU), the Consortium of Swiss Academic Libraries or some UK libraries participating in the Jisc Collections SMP may publish primary research and review articles open access in any of De Gruyter's OnlineOpen journals at a discount of 90% of the APC price. For more information and to confirm whether your institution is eligible please see the following:

    The Netherlands: https://www.degruyter.com/page/1461
    The UK: https://www.degruyter.com/page/1462
    Switzerland: https://www.degruyter.com/page/1463

    More ...


    EJNM was founded in 2008 as the official publishing organ of the CLINAM (European Foundation for Clinical Nanomedicine)

    The first issue of Volume 4 in 2012 was the first to be published at De Gruyter

    Other publications in the field

    Abstracting & Indexing

    European Journal of Nanomedicine is covered by the following services:

    • Baidu Scholar
    • Case
    • Celdes
    • Chemical Abstracts Service (CAS) - CAplus
    • Chemical Abstracts Service (CAS) - SciFinder
    • Clarivate Analytics - Emerging Sources Citation Index
    • CNKI Scholar (China National Knowledge Infrastructure)
    • CNPIEC
    • EBSCO (relevant databases)
    • EBSCO Discovery Service
    • Elsevier - Compendex
    • Elsevier - EMBASE
    • Elsevier - Engineering Village
    • Elsevier - Reaxys
    • Elsevier - SCOPUS
    • Genamics JournalSeek
    • Google Scholar
    • J-Gate
    • JournalGuide
    • JournalTOCs
    • KESLI-NDSL (Korean National Discovery for Science Leaders)
    • Meta (formerly Sciencescape)
    • Microsoft Academic
    • Naviga (Softweco)
    • Paperbase
    • Pirabase
    • Polymer Library
    • Primo Central (ExLibris)
    • ProQuest (relevant databases)
    • ReadCube
    • ResearchGate
    • SCImago (SJR)
    • Sherpa/RoMEO
    • Summon (Serials Solutions/ProQuest)
    • TDNet
    • Ulrich's Periodicals Directory/ulrichsweb
    • WanFang Data
    • WorldCat (OCLC)

    Editorial Information

    Patrick Hunziker, University Hospital Basel, Switzerland
    Jan Mollenhauer, Board of Trustees, European Foundation for Clinical Nanomedicine (CLINAM), Basel, Switzerland

    Scientific Managing Editor
    Georgette Salieb-Beugelaar, University Hospital Basel, Switzerland

    Managing Editor CLINAM
    Beat Löffler, European Foundation for Clinical Nanomedicine, Basel, Switzerland

    Christoph Alexiou, University Hospital Erlangen, Germany
    Yechezkel Barenholz, The Hebrew University of Jerusalem, Israel
    Kenneth Dawson, University College Dublin, Ireland
    Rutledge Ellis-Behnke, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
    Bengt Fadeel, Karolinska Institutet, Stockholm, Sweden
    Silke Krol, Neurological Institute Foundation Carlo Besta, Milan, Italy
    Dong Soo Lee, Seoul National University, Seoul, South Korea
    Claus-Michael Lehr, Saarland University, Saarbrücken, Germany
    Eder-Lilia Romero, Quilmes National University, Bernal, Buenos Aires, Argentina
    Simó Schwartz, Vall d'Hebron University Hospital, Barcelona, Spain
    Janos Szebeni, Semmelweis University, Budapest, Hungary

    Editorial Board
    Ghaleb Husseini, American University of Sharjah, Sharjah, United Arab Emirates
    Harald Mangge, Medical University of Graz, Graz, Austria
    Bert Müller, University of Basel, Switzerland
    Dan Peer, Tel Aviv University, Tel Aviv, Israel
    Giacinto Scoles, Princeton University, Princeton, New Jersey, USA
    Patrick W. Serruys, Erasmus University Medical Center, Rotterdam, The Netherlands

    Editorial Advisor
    Lajos Balogh, AA Nanomedicine & Nanotechnology Consultants, Boston, Massachusetts, USA

    Editorial Office - Contact
    Alexandra Hinz
    De Gruyter
    Genthiner Straße 13
    10785 Berlin
    Tel.: +49 (0)30 260 05 - 358
    Fax: +49 (0)30 260 05 - 184
    E-Mail: editorial.nanomedicine@degruyter.com
    Web: www.degruyter.com/journals/ejnm

    Comments (0)

    Please log in or register to comment.
    Log in